Acute Alcoholic Hepatitis: Therapy

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Alcoholic hepatitis (AH) is a significant cause of liver disease morbidity and mortality globally.
• Therapeutic advancements for AH have been hindered by diagnostic challenges, particularly differentiating it from acute-on-chronic liver failure.
• Accurate diagnosis is crucial for effective management of alcoholic hepatitis.

Purpose of the Study:

• To highlight the diagnostic challenges in alcoholic hepatitis.
• To emphasize the role of liver biopsy in complex cases.
• To outline current treatment strategies for alcoholic hepatitis.

Main Methods:

• Review of diagnostic criteria for alcoholic hepatitis.
• Discussion of the utility of liver biopsy in differentiating AH from other liver conditions.
• Summary of established treatment protocols for AH.

Main Results:

• Liver biopsy is the definitive method for diagnosis when clinical data are ambiguous.
• Distinguishing AH from acute-on-chronic liver failure requires careful clinical assessment and often invasive procedures.
• Standard treatment includes alcohol abstinence and nutritional support.

Conclusions:

• Effective management of alcoholic hepatitis relies on accurate diagnosis, with liver biopsy playing a key role in challenging cases.
• Alcohol abstinence and nutritional support are foundational treatments for all patients with AH.
• Prednisolone is the primary pharmacologic agent for severe alcoholic hepatitis.